产品

临床试验搜索来自全球注册库的 100 万余项试验药物情报追踪药物从研发到审批的全流程深度研究借助先进的 AI 分析工具，深入挖掘临床试验洞察。

美国 FDA 药品欧盟 EMA 药品新加坡 HSA 药品中国 NMPA 药品澳大利亚 TGA 药品加拿大 HC 药品西班牙 CIMA-AEMPS 药品英国 EMC 药品沙特 SFDA 药品马来西亚 NPRA 药品菲律宾 FDA 药品肯尼亚 PPB 药品

机构资讯 AI 研究

临床试验搜索

搜索并筛选全球 100 万余项临床试验

阶段

早期 1 期1 期1/2 期2 期2/3 期3 期4 期不适用

状态

招募中尚未招募进行中（未招募）已完成暂停终止撤回

地点

开始日期范围

从

至

共显示 23 条结果

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

GlaxoSmithKline•Influenza, Human

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

BioNTech SE•Influenza

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

ModernaTX, Inc.•SARS-CoV-2

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years

National Institute of Allergy and Infectious Diseases (NIAID)•Influenza

Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone

National Institute of Allergy and Infectious Diseases (NIAID)•Influenza

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

GlaxoSmithKline•Influenza

VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years

National Institute of Allergy and Infectious Diseases (NIAID)•Influenza, Human

60 人入组2009年10月16日

跳至

临床试验搜索

搜索并筛选全球 100 万余项临床试验

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

临床试验搜索

搜索并筛选全球 100 万余项临床试验

阶段

早期 1 期1 期1/2 期2 期2/3 期3 期4 期不适用

状态

招募中尚未招募进行中（未招募）已完成暂停终止撤回

地点

开始日期范围

从

至

共显示 23 条结果

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

GlaxoSmithKline•Influenza, Human

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

BioNTech SE•Influenza

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

ModernaTX, Inc.•SARS-CoV-2

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years

National Institute of Allergy and Infectious Diseases (NIAID)•Influenza

Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone

National Institute of Allergy and Infectious Diseases (NIAID)•Influenza

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

GlaxoSmithKline•Influenza

VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years

National Institute of Allergy and Infectious Diseases (NIAID)•Influenza, Human

60 人入组2009年10月16日

跳至